trending Market Intelligence /marketintelligence/en/news-insights/trending/h7HBV7D619Pwr8v10QZaoQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

UPDATE: Activist investor Starboard nominates directors to Mednax board

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

UPDATE: Activist investor Starboard nominates directors to Mednax board

Mednax Inc. said Starboard Value LP has nominated a majority slate of directors for the company's board.

The activist investor is also urging Mednax to sell the entire company or part of itself, The Wall Street Journal reported, citing people familiar with the matter.

In a Dec. 11 Form 8-K filing, Mednax said it already met with Starboard as a new shareholder. The company noted that it welcomes a constructive dialogue with the investor.

S&P Global Ratings in October downgraded the company's long-term issuer credit rating to BB from BBB- on weak performance.

The same month, the company agreed to sell its MedData LLC unit to private equity firm Frazier Healthcare Partners to focus on its core physician services business and significantly reduce leverage and future capital expenditures.

Sunrise, Fla.-based Mednax has a market capitalization of $2.06 billion.